Amgen Inc. provided earnings guidance for the year ending December 31, 2013. For the year, the company expected total revenues to be in the range of $17.8 billion to $18.2 billion, GAAP EPS in the range of $6.46 to $6.76 and adjusted EPS to be in the range of $6.85 to $7.15. They expect adjusted tax rate to be in the range of 14% to 15%.

This reflects the impact of the foreign tax credit associated with the Puerto Rico excise tax. Excluding the Puerto Rico excise tax, Amgen expects the adjusted tax rate for 2013 to be in the range of 17% to 18%. Capital expenditures guidance to be approximately $700 million.